| Sofosbuvir-based therapy in hepatitis C virus-infected cancer patients: a prospective observational study HA Torres, MP Economides, G Angelidakis, J Hosry, A Kyvernitakis, ... Official journal of the American College of Gastroenterology| ACG 114 (2 …, 2019 | 24 | 2019 |
| Hepatitis C virus-associated hepatocellular carcinoma as a second primary malignancy: exposing an overlooked presentation of liver cancer D Dandachi, M Hassan, A Kaseb, G Angelidakis, HA Torres Journal of hepatocellular carcinoma, 81-86, 2018 | 10 | 2018 |
| Clinicopathologic characteristics of follicular lymphoma in hepatitis C virus‐infected patients J Hosry, RN Miranda, F Samaniego, G Angelidakis, HA Torres Hematological Oncology 38 (3), 301-308, 2020 | 9 | 2020 |
| Genomic and Functional Characterization of Vancomycin-Resistant Enterococci-Specific Bacteriophages in the Galleria mellonella Wax Moth Larvae Model L El Haddad, G Angelidakis, JR Clark, JF Mendoza, AL Terwilliger, ... Pharmaceutics 14 (8), 1591, 2022 | 8 | 2022 |
| Universal screening for hepatitis C: a needed approach in patients with haematologic malignancies G Angelidakis, JP Hwang, D Dandachi, MP Economides, J Hosry, ... Journal of Viral Hepatitis 25 (9), 1102-1104, 2018 | 8 | 2018 |
| Combination of baloxavir and oseltamivir for treatment of severe influenza infection in hematopoietic cell transplant recipients: a novel treatment strategy for a high-risk … G Angelidakis, F Khawaja, VE Mulanovich, N Dailey-Garnes, ... Microbes and Infection 24 (3), 104895, 2022 | 5 | 2022 |
| Virologic Impact of Radiotherapy in Hepatitis C Virus‐Infected Patients With Hepatocellular Carcinoma G Angelidakis, S Krishnan, NL Cabrera, Y Jiang, B Pushparaji, A Kaseb, ... Hepatology 72 (2), 775-777, 2020 | 5 | 2020 |
| Inhibition of hepatitis C virus replication induced by chemotherapy: A prospective observational study J Hosry, G Angelidakis, A Kaseb, Y Jiang, HA Torres Clinical Infectious Diseases 67 (10), 1635-1636, 2018 | 4 | 2018 |
| Chronic hepatitis C virus infection in patients with nonoropharyngeal head and neck cancers G Angelidakis, EM Sturgis, MP Economides, Y Jiang, HA Torres Oral oncology 85, 103-105, 2018 | 4 | 2018 |
| Electroacupuncture for the treatment of calcific tendonitis. A pilot study G Papadopoulos, A Mavrodontidis, A Liarmakopoulou, P Tzimas, ... Journal of Acupuncture and Meridian Studies 11 (2), 47-53, 2018 | 4 | 2018 |
| Cytomegalovirus (CMV) reactivation within in the first year after chimeric antigen receptor (CAR) T cell therapy: experience from the first two years at a major cancer center F Khawaja, R Prakash, J Sassine, G Handley, T VanWieren, ... Blood 140 (Supplement 1), 7533-7535, 2022 | 2 | 2022 |
| Strategies to identify hepatitis C virus infection in patients receiving anticancer therapy: a cross-sectional study HA Torres, AS Lok, ME Suarez-Almazor, CL Warneke, A Kaseb, E Miller, ... Supportive Care in Cancer 29, 97-105, 2021 | 2 | 2021 |
| Hepatitis c virus infection risk tool for patients with cancer. J Hwang, HA Torres, A Lok, ME Suarez-Almazor, CL Warneke, E Miller, ... Journal of Clinical Oncology 36 (15_suppl), e18694-e18694, 2018 | 2 | 2018 |
| COVID‐19 in cancer patients: The impact of vaccination on outcomes early in the pandemic F Khawaja, G Angelidakis, A Feldman, V Ravi, E Woodman, M Bhatti, ... Cancer medicine 12 (24), 22006-22022, 2023 | 1 | 2023 |
| High sustained virologic response rate after 8 weeks of direct-acting antivirals in cancer patients with chronic hepatitis C virus M Yibirin, J Hosry, EY Guevara, BP Granwehr, Y Jiang, K Mustafayev, ... European Journal of Gastroenterology & Hepatology 34 (10), 1098-1101, 2022 | 1 | 2022 |
| Serologic versus molecular testing for screening for hepatitis C virus infection in patients with hematologic malignancies HA Torres, G Angelidakis, Y Jiang, M Economides, K Mustafayev, ... Medicine 101 (37), e30608, 2022 | 1 | 2022 |
| Impact of CD4+ T-cell count on sustained virologic response to direct-acting antivirals in hepatitis C virus monoinfected cancer patients: a prospective observational study G Angelidakis, H Pritchard, M Yibirin, Y Jiang, K Mustafayev, HA Torres Diagnostic Microbiology and Infectious Disease 103 (3), 115719, 2022 | 1 | 2022 |
| 15. Evaluation of Retained Immunity for Tetanus-Diphtheria and Pneumococcal Vaccines in Recipients of Cellular Therapies G Angelidakis, RF Chemaly, P Kebriaei, NJ Ajami, MM Bhatti, E Shpall, ... Open Forum Infectious Diseases 8 (Supplement_1), S131-S132, 2021 | 1 | 2021 |
| Salvage therapy in cancer patients with hepatitis C without sustained virologic response after direct‐acting antivirals—A prospective study H Pritchard, D Jandhyala, J Hosry, G Angelidakis, HA Torres JGH Open 4 (3), 541-544, 2020 | 1 | 2020 |
| 2227. Short-Duration of Direct-Acting Antivirals in Hepatitis C Virus-Infected Cancer Patients J Hosry, G Angelidakis, B Granwehr, H Torres Open Forum Infectious Diseases 5 (Suppl 1), S658, 2018 | 1 | 2018 |
